Pacemakers

Adapta™ pacemaker

Pacemakers

Adapta™ pacemaker

The Adapta™ pacing system includes pacing with automaticity.

Description

With managed ventricular pacing (MVP™) to pace less

Adapta™ DR is the first pacemaker with managed ventricular pacing (MVP™) technology, which reduces unnecessary right ventricular pacing by 99%.1 Reducing unnecessary ventricular pacing has been shown to improve clinical outcomes by reducing the risks of atrial fibrillation (AF)2–5 and heart failure hospitalization (HFH).2,5

Ordering information

Item number Description Volume (mL) Size — height × width × depth (mm)
Connector Battery type / voltage
ADDR01 Adapta™ DR 12.1 44.7 × 47.9 × 7.5 IS-1 BI or UNI Lithium-iodine / 2.8V
ADDR03 Adapta™ DR 13.0 46.7 × 47.9 × 7.5 3.2 mm LP BI, IS-1 BI, or UNI Lithium-iodine / 2.8V
ADDR06 Adapta™ DR 14.2 50.3 × 47.9 × 7.5 5 or 6 mm UNIa Lithium-iodine / 2.8V
ADDRS1 Adapta™ DR 11.1 44.7 × 42.9 × 7.5 IS-1 BI or UNI Lithium-iodine / 2.8V
ADDRL1 Adapta™ DR 13.1 45.4 × 52.3 × 7.5 IS-1 BI or UNI Lithium-iodine / 2.8V
ADD01 Adapta™ D
ADVDD01 Adapta™ VDD 11.1 44.7 × 42.9 × 7.5 IS-1 BI or UNI Lithium-iodine / 2.8V
ADSR01 Adapta™ SR 9.7 40.2 × 42.9 × 7.5 IS-1 BI or UNI Lithium-iodine / 2.8V
ADSR03 Adapta™ SR 10.5 42.9 × 42.9 × 7.5 3.2 mm LP BI, IS-1 BI, or UNI Lithium-iodine / 2.8V
ADSR06 Adapta™ SR 11.0 43.3 × 42.9 × 7.5 5 or 6 mm UNI Lithium-iodine / 2.8V

Parylene coating on backside of case


  1. Gillis A, Pürerfellner H, Israel C, et al. Reduction of unnecessary ventricular pacing due to the managed ventricular pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Presented at HRS 2005 (Abstract AB21-1).
  2. Anderson HR, et al. Lancet. 1997;350:1210–1216.
  3. Skanes AC, et al.  J Am Coll Cardiol. 2001;38:167–172.
  4. Neilsen J, et al.  J Am Coll Cardiol. 2003;42:614–623.
  5. Sweeney M, et al. Circulation. 2003;107:2932–2937.